Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41

Journal of Cell Biology

Volumn 140, Issue 2, 1998, Pages 315-323

  Muñoz Barroso, Isabel ^a   Durell, Stewart ^a   Sakaguchi, Kazuyasu ^b   Appella, Ettore ^b   Blumenthal, Robert ^a,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Building 469 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CD4 ANTIGEN; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; LIPID; SYNTHETIC PEPTIDE; VIRUS ENVELOPE PROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; ASSAY; CELL FUSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS ENVELOPE;

ANTI-HIV AGENTS; CELL FUSION; GENES, REPORTER; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; KINETICS; MICROSCOPY, VIDEO; PEPTIDE FRAGMENTS; TUMOR CELLS, CULTURED;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0038065763     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.140.2.315     Document Type: Article

References (49)

1. Bentz, J., H. Ellens, and D. Alford. 1990. An architecture for the fusion site of influenza hemagglutinin. FEBS (Fed. Eur. Biochem. Soc.) Lett. 276:1-5.
2. Blumenthal, R. 1988. Cooperativity in viral fusion. Cell. Biophys. 12:1-12.
3. Blumenthal, R., and D.S. Dimitrov. 1997. Membrane fusion. In Handbook of Physiology. J.F. Hoffman, and J.C. Jamieson, editors. Oxford University Press, New York. 569-604.
4. Blumenthal, R., C. Schoch, A. Puri, and M.J. Clague. 1991. A dissection of steps leading to viral envelope protein-mediated membrane fusion. Ann. NY Acad. Sci. 635:285-296.
5. Blumenthal, R., C.C. Pak, Y. Raviv, M. Krumbiegel, L.D. Bergelson, S.J. Morris, and R.J. Lowy. 1995. Transient domains induced by influenza haemagglutinin during membrane fusion. Mol. Membr. Biol. 12:135-142.
6. Blumenthal, R., D.P. Sarkar, S. Durell, D.E. Howard, and S.J. Morris. 1996. Dilation of the influenza hemagglutinin fusion pore revealed by the kinetics of individual cell-cell fusion events. J. Cell Biol. 135:63-71.
7. Broder, C.C., and E.A. Berger. 1995. Fusogenic selectivity of the envelope glycoprotein is a major determinant of human immunodeficiency virus type 1 tropism for CD4+ T-cell lines vs. primary macrophages. Proc. Natl. Acad. Sci. USA. 92:9004-9008.
8. Bullough, P.A., F.M. Hughson, J.J. Skehel, and D.C. Wiley. 1994. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature. 371: 37-43.
9. Carr, C.M., and P.S. Kim. 1993. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell. 73:823-832.
10. Chan, D.C., D. Fass, J.M. Berger, and P.S. Kim. 1997. Core structure of gp41 from the HIV envelope glycoprotein. Cell. 89:263-273.
11. Chen, C.H., T.J. Matthews, C.B. McDanal, D.P. Bolognesi, and M.L. Greenberg. 1995. A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: implication for viral fusion. J. Virol. 69:3771-3777.
12. Chernomordik, L.V., G.B. Melikyan, and Y.A. Chizmadzhev. 1987. Biomembrane fusion: a new concept derived from model studies using two interacting planar lipid bilayers. Biochim. Biophys. Acta. 906:309-352.
13. Danieli, T., S.L. Pelletier, Y.I. Henis, and J. M. White. 1996. Membrane fusion mediated by the influenza virus hemagglutinin requires the concerted action of at least three hemagglutinin trimers. J. Cell. Biol. 133: 559-569.
14. Dimitrov, D.S., and R. Blumenthal. 1994. Photoinactivation and kinetics of membrane fusion mediated by the human immunodeficiency type 1 envelope glycoprotein. J. Virol. 68:1956-1961.
15. Earl, P.L., S. Koenig, and B. Moss. 1991. Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses. J. Virol. 65:31-41.
16. Ellens, H., J. Bentz, D. Mason, F. Zhang, and J.M. White. 1990. Fusion of influenza hemagalutinin-expressing fibroblasts with glycophorin-bearing liposomes: role of hemagglutinin surface density. Biochemistry. 29:9697-9707.
17. Fass, D., S.C. Harrison, and P.S. Kim. 1996. Retrovirus envelope domain at 1.7 angstrom resolution. Nat. Struct. Biol. 3:465-469.
18. Feng, Y., C.C. Broder, P.E. Kennedy, and E.A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 272:872-877.
19. Fu, Y.K., T.K. Hart, Z.L. Jonak, and P.J. Bugelski. 1993. Physicochemical dissociation of CD4-mediated syncytium formation and shedding of human immunodeficiency virus type 1 gp120. J. Virol. 67:3818-3825.
20. Gallaher, W.R., J.M. Ball, R.F. Garry, M.C. Griffin, and R.C. Montelaro. 1989. A general model for the transmembrane proteins of HIV and other retroviruses. AIDS Res. Hum. Retroviruses. 5:431-440.
21. Jones, P., T. Korte, and R. Blumenthal. 1998. Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and coreceptors. J. Biol. Chem. 273:404-409.
22. Kemble, G.W., T. Danieli, and J.M. White. 1994. Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion. Cell. 76:383-391.
23. Kowalski, M., J. Potz, L. Basiripour, T. Dorfman, W.C. Goh, E. Terwilliger, A. Dayton, C. Rosen, W. Haseltine, and J. Sodroski. 1987. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science. 237:1351-1355.
24. Lawless, M.K., S. Barney, K.I. Guthrie, T.B. Bucy, S.R. Petteway, Jr., and G. Merutka. 1996. HIV-1 membrane fusion mechanism: structural studies of the interactions between biologically-active peptides from gp41. Biochemistry. 35:13697-13708.
25. Lu, M., S.C. Blacklow, and P.S. Kim. 1995. A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nat. Struct. Biol. 2:1075-1082.
26. Maddon, P.J., A.G. Dalgleish, J.S. McDougal, P.R. Clapham, R.A. Weiss, and R. Axel. 1986. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell. 47:333-348.
27. Matthews, T.J., C. Wild, C.H. Chen, D.P. Bolognesi, and M.L. Greenberg. 1994. Structural rearrangements in the transmembrane glycoprotein after receptor binding. Immunol. Rev. 140:93-104.
28. Melikyan, G.B., J.M. White, and F.S. Cohen. 1995. GPI-anchored influenza hemagglutinin induces hemifusion to both red blood cell and planar bilayer membranes. J. Cell Biol. 131:679-691.
29. 28a. Melikyan, G.B., S.A. Brener, D.C. Ok, and F.S. Cohen. 1997. Inner but not outer membrane leaflets control the transition from glycosylphosphatidylinositol-anchored influenza hemagglutinin-induced hemifusion to full fusion. J. Cell Biol. 136:995-1005.
30. Monck, J.R., and J.M. Fernandez. 1996. The fusion pore and mechanisms of biological membrane fusion. Curr. Opin. Cell Biol. 8:524-533.
31. Moore, J.P., B.A. Jameson, R.A. Weiss, and Q.J. Sattentau. 1993. The HIV-cell fusion reaction. In Viral Fusion Mechanisms. J. Bentz, editor. CRC Press. Boca Raton. 233-289.
32. Morris, S.J., D.P. Sarkar, J.M. White, and R. Blumenthal. 1989. Kinetics of pH-dependent fusion between 3T3 fibroblasts expressing influenza hemagglutinin and red blood cells. Measurement by dequenching of fluorescence. J. Biol. Chem. 264:3972-3978.
33. Nussbaum, O., C.C. Broder, and E.A. Berger. 1994. Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation. J. Virol. 68:5411-5422.
34. Puri, A., S.J. Morris, P. Jones, M. Ryan, and R. Blumenthal. 1996. Heat-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing HIV-1 envelope glycoproteins. Virology. 219:262-267.
35. Sarkar, D.P., S.J. Morris, O. Eidelman, J. Zimmerberg, and R. Blumenthal. 1989. Initial stages of influenza hemagglutinin-induced cell fusion monitored simultaneously by two fluorescent events: Cytoplasmic continuity and lipid mixing. J. Cell Biol. 109:113-122.
36. Sattentau, Q.J., and J.P. Moore. 1991. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J. Exp. Med. 174:407-415.
37. Schoch, C., and R. Blumenthal. 1993. Role of the fusion peptide sequence in initial stages of influenza hemagglutinin-induced cell fusion. J. Biol. Chem. 268:9267-9274.
38. Spruce, A.E., A. Iwata, J.M. White, and W. Almers. 1989. Patch clamp studies of single cell-fusion events mediated by a viral fusion protein. Nature. 342:555-558.
39. Weiss, C.D., J.A. Levy, and J.M. White. 1990. Oligomeric organization of gp120 on infectious human immunodeficiency virus type 1 particles. J. Virol. 64:5674-5677.
40. Weiss, C.D., S.W. Barnett, N. Cacalano, N. Killeen, D.R. Littman, and J.M. White. 1996. Studies of HIV-1 envelope glycoprotein-mediated fusion using a simple fluorescence assay. AIDS. 10:241-246.
41. Weissenhorn, W., S.A. Wharton, L.J. Calder, P.L. Earl, B. Moss, E. Aliprandis, J.J. Skehel, and D.C. Wiley. 1996. The ectodomain of HIV-1 env subunit gp41 forms a soluble, alpha-helical, rod-like oligomer in the absence of gp120 and the N-terminal fusion peptide. EMBO (Eur. Mol. Biol. Organ.) J. 15:1507-1514.
42. Weissenhorn, W., A. Dessen, S.C. Harrison, J.J. Skehel, and D.C. Wiley. 1997. Atomic Structure of the Ectodomain from HIV-1 gp41. Nature. 387:426-428.
43. White, J.M. 1992. Membrane fusion. Science. 258:917-924.
44. White, J.M. 1995. Membrane fusion: the influenza paradigm. Cold Spring Harbor Symp. Quant. Biol. 60:581-588.
45. Wild, C., T. Oas, C. McDanal, D. Bolognesi, and T. Matthews. 1992. A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition. Proc. Natl. Acad. Sci. USA. 89:10537-10541.
46. Wild, C., T. Greenwell, and T. Matthews. 1993. A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion. AIDS Res. Hum. Retroviruses. 9:1051-1053.
47. Wild, C.T., D.C. Shugars, T.K. Greenwell, C.B. McDanal, and T.J. Matthews. 1994. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc. Natl. Acad. Sci. USA. 91:9770-9774.
48. Wild. C., T. Greenwell, D. Shugars, L. Rimsky-Clarke, and T. Matthews. 1995. The inhibitory activity of an HIV type 1 peptide correlates with its ability to interact with a leucine zipper structure. AIDS Res. Hum. Retroviruses. 11:323-325.
49. Zimmerberg, J., R. Blumenthal, D.P. Sarkar, M. Curran, and S.J. Morris. 1994. Restricted movement of lipid and aqueous dyes through pores formed by influenza hemagglutinin during cell fusion. J. Cell Biol. 127: 1885-1894.